Display Post Content

SNAC introduce latest experience in Quantitative Neuroimaging Analysis at GTC Digital

The director of operations in Sydney Neuroimaging Analysis Centre, Tim Wang , is honoured to be one of the featured speakers in healthcare & life science sessions at GTC Digital (GTC 2020) , in which he provides the online presentation: “Accelerate Quantitative Clinical Neuroimaging Analysis with AI: Steps Toward Personalised Disease Progression Monitoring in Clinical Neurology”.

 

GTC2.png

GTC (GPU Technology Conference), is an annual gathering hosted by NVIDIA. GTC attracts professionals in the graphics processing unit (GPU) to share experiences in deep learning, cybersecurity, autonomous machines, intelligent video analysis, healthcare etc. Amidst the outbreak of COVID-19, an online conference - GTC Digital has been facilitated, which covers a range of training, research, insights and lead to “direct access to the brilliant minds of NVIDIA GPU Technology Conference 2020”.

 

GTC2.png

Dr. Tim Wang will share SNAC’s experience in using quantitative neuroimaging analysis to assist extracting further clinical data in diagnostic imaging. By providing a fine scale measure on monitoring brain-tissue changes in the progression of neurodegenerative disease, and following the quality assurance on analysis contributed by radiologists- then implementing deep learning to assign complex analysis into automation, SNAC is able to carry out its goal of improving efficiency and accuracy in modern clinical practice.

 

For more details please go to the following link:   

 https://www.nvidia.com/en-us/gtc/session-catalog/?search=21421#/

For more information please contact:   

Email: info@snac.com.au

Web: snac.com.au

The role of project officer is to provide overall project management to support implementation of key strategies and programs of work of the CRC-P in SNAC. This role will be focused on operationalising a multidisciplinary and collaborative project to improve clinical and research neuroimaging outcomes with artificial intelligence. The project manager will develop project architecture, charter, workforce plans and processes; and manage resources required to support implementation, which will lead to effective management of activities and deliverables to ensure milestones and deliverables are realised.

Overview of SNAC

The Interdisciplinary collaboration between the University of Sydney, SNAC and I-MED will build a new hybrid learning system to look deep within the brain for disease biomarkers. These biomarkers, which signify progression of the disease beyond clinical presentation, make early diagnosis and intervention possible and will change the course of MS for people diagnosed with the disease. The project will establish a unique central-federated AI learning environment, yielding algorithms that, validated in a clinical neurology environment, will set a benchmark in diagnostic MS imaging; track subclinical progression of the disease; direct therapeutic strategy; and mine untapped quantitative imaging data. The collaboration is centred on industry-led innovation within the government science and research priority of HEALTH and aligns with the Medical Technologies and Pharmaceuticals growth sector. 

The University of Sydney is Australia’s premier University with an outstanding global reputation for academic and research excellence, and employs over 7600 permanent staff supporting over 60,000 students. The University of Sydney's Brain and Mind Centre was established in 2015 for the research and treatment of critical health issues of the 21st century – disorders of the brain and mind. 

SNAC was established at the Brain Mind Centre to take advantage of unique research capacity in the field and provide a state of the art commercial facility for the quantitative analysis of MRI to the pharmaceutical and other industries since 2012. Together with a dedicated MS clinic, MS Clinical Trials Centre, and MRI unit, SNAC is co-located within the Brain and Mind Centre at the University of Sydney. SNAC offers a unique combination of in-house neuroscience, imaging science, clinical trial, neurology and radiology expertise; and specialises in building novel neuroimaging biomarkers and integrating these into Phase 2-4 clinical trials for the pharmaceutical industry. 

I-MED Radiology Network is the largest provider of radiology service in Australia, providing over five million services a year to the Australian community across all states. 

Duties and Key Responsibilities 

  • Manages overall project organisation and establishment.
  • Manages the development and implementation of project plans to meet objectives.
  • Develops and embeds project governance and reporting framework to monitor implementation, progress and delivery of the project.
  • Manages project stakeholders and collaborates with project teams to ensure that project deliverables and milestones are achieved.
  • Provides effective leadership and people management and coordination of project staff.  
  • Undertake any other duties relevant and appropriate to the position.
  • Maintain strict confidentiality of all project / commercial materials.
  • Skills, Knowledge and Experience 

  • Tertiary qualifications, skills and 3 - 5 years’ experience in project management and implementation, preferably in a Neuroimaging and AI context.
  • Demonstrated experience in IT or related project management, including scope, time, cost, quality, HR, communications, cost, risk and all other aspects of process development and execution.
  • Excellent interpersonal, verbal and written communication skills with sound negotiating and conflict resolution skills and a demonstrated level of tact and discretion in dealing with a variety of matters.
  • Ability to work both independently and as part of a team, taking initiative and exercising sound judgement in resolving matters that may arise as part of normal daily work.
  • Accuracy, attention to detail and highly organised. Planning, analysis and communication skills together with the ability to work according to strict deadlines and manage various demands.
  • Experience project managing multiple work streams, or leading large complex projects and ability to work according to strict deadlines and manage various demands.
  • Experience managing a diverse group of key internal/external stakeholders on large or complex project.
  • Has previously worked in the higher education/tertiary sector or at a complex, multi-faceted organisation.
  • SNAC is an equal employment opportunity employer committed to equity, diversity and social inclusion. 

    Please forward your application letter and CV to info@snac.com.au. We will be reviewing applications as we receive them however due to the volume of the applications, please be informed that only shortlisted candidates will be contacted after the closing date.

    This is a 6-month contract full-time position. An immediate start is preferable.

    The role of technical writer is to coordinate with various technical professionals to gather, organize and compile information on medical devices, and to provide technical documents and design dossiers to support implementation of medical devices throughout CRC-P project progress at SNAC. This role will be responsible for regulatory submissions to various global bodies including but not limited to the TGA and the FDA. This position also provides regulatory strategy and advice regarding potential areas of regulatory concerns and new regulatory developments within the industry locally and globally.

    Overview of SNAC

    The recent interdisciplinary collaboration between the University of Sydney, SNAC and I-MED will deliver a platform for seamless AI integration into clinical radiology workflows; and develop neuroimaging algorithms that will set a benchmark in diagnostic imaging, drive industry automation and productivity and mine hitherto untapped quantitative imaging data to improve health outcomes. The collaboration is centred on industry-led innovation within the government science and research priority of Health and aligns with the Medical Technologies and Pharmaceuticals growth sector. 

    SNAC was established at the Brain Mind Centre to take advantage of unique research capacity in the field and provide a state of the art commercial facility for the quantitative analysis of MRI to the pharmaceutical and other industries since 2012. Together with a dedicated MS clinic, MS Clinical Trials Centre, and MRI unit, SNAC is co-located within the Brain and Mind Centre at the University of Sydney. SNAC offers a unique combination of in-house neuroscience, imaging science, clinical trial, neurology and radiology expertise; and specialises in building novel neuroimaging biomarkers and integrating these into Phase 2-4 clinical trials for the pharmaceutical industry. 

    Collaborative partners include:

    The University of Sydney. The University of Sydney is Australia’s premier University with an outstanding global reputation for academic and research excellence and employs over 7600 permanent staff supporting over 60,000 students. The University of Sydney's Brain and Mind Centre was established in 2015 for the research and treatment of critical health issues of the 21st century – disorders of the brain and mind.

    I-MED Radiology Network. I-MED Radiology Network is the largest provider of clinical radiology service in Australia, providing over five million services a year to the Australian community across all states.

    Duties and Key Responsibilities 

  • Preparing and maintaining technical files and design dossiers.
  • Compiling, reviewing, and submitting regulatory submissions to various global notified bodies including but not limited to the TGA and the FDA.
  • Participating in cross-functional projects to provide regulatory strategy and oversight for implantable device and technology development projects locally and globally.
  • Driving project improvement across the Regulatory function.
  • Reviewing protocols and reports and other documentation used to support medical device files.  
  • Remaining up to date with changes within the industry and regulatory environments and performing subsequent gap analyses to understand the effect of changes.
  • Providing mentorship and knowledge sharing within the project team.
  • Supporting internal/external audits as required..
  • Skills, Knowledge and Experience 

    Essential 

  • Minimum 2 years of Regulatory Affairs experience working within the Australian Medical Devices industry, medical device/software industry.
  • Able to draft and complete product Technical File for TGA and FDA compliance.
  • A tertiary qualification in medical, Biomedical, or computer science or identical.
  • Proficiency with technical communication and related software.
  • Excellent written and oral communication skills.
  • Experience operating in a 21 CFR.820, ISO 13485 or ISO 9001 QMS.
  • Desirable 

  • Basic knowledge in radiology imaging, machine learning, and image processing techniques.
  • Proficient knowledge of Therapeutic Goods (Medical Devices) Regulations 2002 for Class1, Class 1S/1M/II, etc,.
  • Proficient knowledge of EC Directive 93/42/EEC and EU MDR 2017/745.
  • Proficient knowledge of FDA 21 CFR part 820, 21 CFR Part 892, especially 510(k) submission.
  • SNAC is an equal employment opportunity employer committed to equity, diversity and social inclusion. 

    Please forward your application letter and CV to info@snac.com.au. We will be reviewing applications as we receive them however due to the volume of the applications, please be informed that only shortlisted candidates will be contacted after the closing date.

    This is a 6-month contract full-time position. An immediate start is preferable.

    SNAC Scientists attend AIMed Australia 2019

    AIMed.png

    Sydney Neuroimaging Analysis Centre attended AIMed 2019 on 12-13 November in Sydney. Our AI Scientists acknowledged latest findings and experiences of AI in the medical sphere, especially within radiology and neurology.

     

    AIMed, as the world’s leading event on Artificial Intelligence in Medicine and Healthcare, has a mission statement to “define AI-enabled solutions and create an efficient workplace, with patient outcomes at its core”. It aims to utilise advanced technology to assist medical professionals in enhancing their work. Originated in the US, AIMed now has become an annual multi-disciplinary gathering for AI and medical professionals to trace the latest AI concepts and applications in medicine, in Europe, Asia and Australia.

     

    “AIMed has been yearning to be in Australia as some of the World’s best minds in informatics and intelligence in biomedicine are in that region. In order to be excellent at AI in medicine and healthcare, we need to learn about each country’s health system, AI landscape, and how they solve problems using AI. We very much look forward to this exciting opportunity to learn from each other”. AIMed Chairman and Founder, Chief Intelligence and Innovation Officer of Children’s Hospital of Orange County (CHOC) Dr. Anthony Chang.

     

    revolution.png

    At SNAC, AI scientists are also passionate about the use of data and algorithms to make a difference on current evidence-based medical imaging and clinical use. We are aware of not only the huge impact Artificial Intelligence is able to provide on fast and accurate automatic diagnosis using medical imaging, but also the inherent challenges needed to be overcome. As well as pushing the precision and recall of AI models to a satisfactory level, our AI scientists also contribute to enhancing present medical imaging analysis tools by using deep learning methods, including automatic brain extraction and automatic lesion implanting.

    For more information please contact:   

    Email: info@snac.com.au

    Web: snac.com.au

    Sydney Neuroimaging Analysis Centre showcased its Central Readings Services at ECTRIMS 2019

    EctrimsTeam.png

    During 11-13 September 2019, the Clinical Trial Team from SNAC , demonstrated its multimodal turnkey central reading solution for Phase 2 Remyelination Clinical Trials, at ECTRIMS 2019 in Stockholm, Sweden.

     

    ECTRIMS- European Committee for Treatment and Research in Multiple Sclerosis (MS), started in Europe and has served as world’s largest professional organization for acknowledging and treating multiple sclerosis. ECTRIMS creates and collaborates opportunities for researchers and clinicians worldwide to support clinical research and improve outcomes in MS.

     

    Based on its strong neurology and neuroimaging connections with University of Sydney, neuroimaging services provided by SNAC is complemented by its research power, in which it also derives its educational and training strength on MRI-based outcomes interpretation in Morden clinical trialsBased on its strong neurology and neuroimaging connections with University of Sydney, neuroimaging services provided by SNAC is complemented by its research power, in which it also derives its educational and training strength on MRI-based outcomes interpretation in Morden clinical trials.

     

    At ECTRIMS 2019, a diverse team of neurologists, clinical trial professionals and neuroimaging specialist from SNAC and their collaborators shared their latest perspectives on MS in clinical trial practice and neuroimaging analysis. Our showcase has highlighted SNAC’s unique approach to providing accurate measurements of remyelination in both acute and chronic MS lesions, which use visual systems as a platform, and facilitate testing of emerging remyelinating therapies.

    Ectrims.png

    For more information please contact:   

    Email: info@snac.com.au

    Web: snac.com.au